6900-92-1

Basic information

• Product Name: Lycodoline
• Synonyms: Lycodoline;(1S,8aS,9S,11R,12aS)-Dodecahydro-8a-hydroxy-11-methyl-1,9-ethanobenzo[i]quinolizin-14-one
• CAS NO: 6900-92-1
• Molecular Formula: C16H25NO2
• Molecular Weight: 263.379
• Mol File: 6900-92-1.mol
• Article Data: 0

Chemical Properties

• Melting Point: 180-181℃
• Boiling Point: 412.67 °C at 760 mmHg
• Flash Point: 203.376 °C
• Appearance: /
• Density: 1.19
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.58
• PKA: 15.24±0.40(Predicted)
• CAS DataBase Reference: Lycodoline(CAS DataBase Reference)
• NIST Chemistry Reference: Lycodoline(6900-92-1)
• EPA Substance Registry System: Lycodoline(6900-92-1)

Safety Data

• Hazardous Substances Data: 6900-92-1(Hazardous Substances Data)

Usage

Description

Lycodoline is an alkaloid derived from the Phlegmariurus squarrosus plant, which is known for its anti-cholinesterase activity. This property makes it a potential candidate for various applications in the pharmaceutical and related industries.

Uses

Used in Pharmaceutical Industry:
Lycodoline is used as a therapeutic agent for its anti-cholinesterase activity, which can be beneficial in treating conditions related to the cholinergic system, such as Alzheimer's disease and other cognitive disorders. Its ability to inhibit cholinesterase enzymes helps to increase the levels of acetylcholine, a neurotransmitter crucial for memory and cognitive function.
Used in Research and Development:
In addition to its potential therapeutic applications, Lycodoline can be used as a research tool to study the cholinergic system and the effects of cholinesterase inhibition on various physiological processes. This can lead to a better understanding of the underlying mechanisms of cholinergic-related diseases and the development of new treatment strategies.
Used in Drug Delivery Systems:
Similar to other bioactive compounds, Lycodoline can be incorporated into drug delivery systems to improve its bioavailability, targeting, and overall efficacy. These systems can include nanoparticles, liposomes, or other advanced drug delivery technologies, which can help to protect the alkaloid from degradation, enhance its solubility, and facilitate its controlled release at the site of action.

InChI:InChI=1/C16H25NO2/c1-11-8-12-9-14(18)13-4-2-6-17-7-3-5-16(12,19)15(13,17)10-11/h11-13,19H,2-10H2,1H3/t11-,12+,13-,15+,16+/m1/s1